Inventor · disambiguated record
David A. Lawrence
Also filed as: LAWRENCE DAVID A
5 granted patents·18 pending applications·48 citations·filing 1998–2025
78Inventor score
Top patents by PatentIndex Score
23 records- 0192US6764679B2Antibodies to DcR3 Polypeptide, a TNFR HomologGENENTECH INC·Filed 2001·Granted Jul 20, 2004·38 cites·33 claims
- 0282US6472585B1Cardiotrophin-1 defective mouseGENENTECH INC·Filed 2000·Granted Oct 29, 2002·5 cites·2 claims
- 0377US8350008B2WISP polypeptides and nucleic acids encoding sameGENENTECH INC·Filed 2011·Granted Jan 8, 2013·2 cites·5 claims
- 0474US2010080793A1DcR3 polypeptide, A TNFR homologGENENTECH INC·Filed 2008·Application pending·0 cites
- 0569US2009098603A1Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the sameBOTSTEIN DAVID·Filed 2008·Application pending·0 cites
- 0669US2010221249A1Wisp polypeptides and nucleic acids encoding sameGENENTECH INC·Filed 2009·Application pending·0 cites
- 0764US8198033B2Methods and materials for observing apoptosisAUSTIN CARY D·Filed 2007·Granted Jun 12, 2012·3 cites·9 claims
- 0864US2005196842A1Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the sameGENENTECH INC·Filed 2003·Application pending·0 cites
- 0964US2007077626A1Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the sameGENENTECH INC·Filed 2006·Application pending·0 cites
- 1063US2004175791A1DcR3 polypeptide, a TNFR homologGENENTECH INC·Filed 2003·Application pending·0 cites
- 1162US2004014176A1DcR3 polypeptide, a TNFR homologGENENTECH INC·Filed 2003·Application pending·0 cites
- 1262US2009191184A1DcR3 polypeptide, A TNFR homologGENENTECH INC·Filed 2008·Application pending·0 cites
- 1360US2007041964A1WISP polypeptides and nucleic acids encoding sameBOTSTEIN DAVID·Filed 2006·Application pending·0 cites
- 1459US2011207912A1Fgf-19 nucleic acidsGENENTECH INC·Filed 2011·Application pending·0 cites
- 1559US2007042395A1Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesityGENENTECH INC·Filed 2006·Application pending·0 cites
- 1656US2025306023A1Methods and systems of predicting multisystem inflammatory syndrome in children (mis-c)UNIV CONNECTICUT·Filed 2025·Application pending·0 cites
- 1756US2002146707A1Cardiotrophin-1 compositions and methods for the treatment of tumorGENENTECH INC·Filed 2001·Application pending·0 cites
- 1855US2007160618A1Cardiotrophin-1 compositions and methods for the treatment of tumorBOTSTEIN DAVID·Filed 2006·Application pending·0 cites
- 1955US2007274995A1Cardiotrophin-1 compositions and methods for the treatment of tumorGENENTECH INC·Filed 2006·Application pending·0 cites
- 2054US7258983B2Cardiotrophin-1 compositions and methods for the treatment of tumorGENENTECH INC·Filed 2004·Granted Aug 21, 2007·0 cites·3 claims
- 2151US2004231011A1DcR3 polypeptide, a TNFR homologGENENTECH INC·Filed 2004·Application pending·0 cites
- 2248US2002102622A1Cardiotrophin-1 compositions and methods for the treatment of tumorGENENTECH INC·Filed 2001·Application pending·0 cites
- 2334US2002012961A1Fibroblast growth factor- 19GENENTECH INC·Filed 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David A. Lawrence files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →